Literature DB >> 26762996

Ethics of ART interruption after stem-cell transplantation.

Jeremy Sugarman1, Sharon R Lewin2, Timothy J Henrich3, Thomas A Rasmussen4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26762996     DOI： 10.1016/S2352-3018(15)00248-9

Source DB:  PubMed          Journal:  Lancet HIV        ISSN： 2352-3018            Impact factor:   12.767


× No keyword cloud information.
  11 in total

1.  "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.

Authors:  Karine Dubé; David Evans; Lynda Dee; Laurie Sylla; Jeff Taylor; Asheley Skinner; Bryan J Weiner; Sandra B Greene; Stuart Rennie; Joseph D Tucker
Journal:  AIDS Res Hum Retroviruses       Date:  2017-07-10       Impact factor: 2.205

2.  Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.

Authors:  Richard F Ambinder; Juan Wu; Brent Logan; Christine M Durand; Ryan Shields; Uday R Popat; Richard F Little; Deborah K McMahon; Joshua Cyktor; John W Mellors; Ernesto Ayala; Lawrence D Kaplan; Ariela Noy; Richard J Jones; Alan Howard; Stephen J Forman; David Porter; Carlos Arce-Lara; Paul Shaughnessy; Lisa Sproat; Shahrukh K Hashmi; Adam M Mendizabal; Mary M Horowitz; Willis H Navarro; Joseph C Alvarnas
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-04       Impact factor: 5.742

Review 3.  Haemopoietic cell transplantation in patients living with HIV.

Authors:  Richard F Ambinder; Adam A Capoferri; Christine M Durand
Journal:  Lancet HIV       Date:  2020-08-10       Impact factor: 12.767

4.  Research on HIV cure: Mapping the ethics landscape.

Authors:  Karine Dubé; Laurie Sylla; Lynda Dee; Jeff Taylor; David Evans; Carl Dean Bruton; Adam Gilberston; Lisa Gralinski; Brandon Brown; Asheley Skinner; Bryan J Weiner; Sandra B Greene; Amy Corneli; Adaora A Adimora; Joseph D Tucker; Stuart Rennie
Journal:  PLoS Med       Date:  2017-12-08       Impact factor: 11.069

5.  Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.

Authors:  Gail E Henderson; Holly L Peay; Eugene Kroon; Rosemary Jean Cadigan; Karen Meagher; Thidarat Jupimai; Adam Gilbertson; Jill Fisher; Nuchanart Q Ormsby; Nitiya Chomchey; Nittaya Phanuphak; Jintanat Ananworanich; Stuart Rennie
Journal:  J Med Ethics       Date:  2017-11-10       Impact factor: 2.903

6.  Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading.

Authors:  Karine Dubé; Lynda Dee
Journal:  J Virus Erad       Date:  2020-04-30

7.  How to Address the Risk of HIV Transmission in Remission Studies With Treatment Interruption: The Low-Hanging Fruit Approach.

Authors:  Nir Eyal
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

8.  Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium.

Authors:  Nir Eyal; Steven G Deeks
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

Review 9.  Ethics of HIV cure research: an unfinished agenda.

Authors:  Karine Dubé; John Kanazawa; Jeff Taylor; Lynda Dee; Nora Jones; Christopher Roebuck; Laurie Sylla; Michael Louella; Jan Kosmyna; David Kelly; Orbit Clanton; David Palm; Danielle M Campbell; Morénike Giwa Onaiwu; Hursch Patel; Samuel Ndukwe; Laney Henley; Mallory O Johnson; Parya Saberi; Brandon Brown; John A Sauceda; Jeremy Sugarman
Journal:  BMC Med Ethics       Date:  2021-06-30       Impact factor: 2.834

10.  Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations.

Authors:  Samual A Garner; Stuart Rennie; Jintanat Ananworanich; Karine Dube; David M Margolis; Jeremy Sugarman; Randall Tressler; Adam Gilbertson; Liza Dawson
Journal:  J Virus Erad       Date:  2017-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.